Scientific Knowledge
Biohaven Ltd.
Company
Publicly traded biopharmaceutical company. Developer of opakalim (BHV-7000), a Kv7.2/7.3 channel activator for focal epilepsy and depression with no tinnitus program, and separately of BHV-1955, an intranasal oxytocin spray that is the company's actual tinnitus candidate.
Explore connections· click any item to explore
Mechanisms14
Kv7.2/3 (KCNQ2/3) ChannelsVoltage-Dependent Gating ShiftDCN Fusiform Cell HyperactivityVulnerability vs. ResilienceThalamocortical DysrhythmiaTinnitus Core SubnetworkTheta-Gamma Cross-Frequency CouplingBayesian Prediction ErrorNoise-Cancelling DeficitAversive Memory NetworkLimbic Gating FailureAmygdala-Auditory Cortex ConnectivityDefault Mode NetworkSalience Network